<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="141332">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02033083</url>
  </required_header>
  <id_info>
    <org_study_id>laminariavsdilapan</org_study_id>
    <nct_id>NCT02033083</nct_id>
  </id_info>
  <brief_title>Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation</brief_title>
  <official_title>Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Planned Parenthood of New York City, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Society of Family Planning</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Planned Parenthood of New York City, Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary objective: To study the difference in dilation and evacuation (D&amp;E) procedure time
      following overnight cervical preparation with laminaria or Dilapan-S™. The investigators
      hypothesize procedure time will be less with Dilapan-S™.

      Secondary objectives:  To compare the use of laminaria and Dilapan-S™ for differences in:
      (1) initial cervical dilation before D&amp;E; (2) need for mechanical dilation to accomplish D&amp;E
      and ease of dilation if required; (3) number of osmotic dilators placed; (4) ability to
      complete the D&amp;E procedure without further cervical preparation; (5) complications; (6) pain
      and other side effects; (7) patient acceptability; and (8) provider acceptability.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>D&amp;E procedure time</measure>
    <time_frame>The primary outcome measure will be assessed on the day of the patient's D&amp;E procedure. (day 2)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Second Trimester Abortion</condition>
  <arm_group>
    <arm_group_label>Laminaria</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will receive laminaria cervical dilators one day before D&amp;E procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dilapan-S</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will receive Dilapan-S cervical dilators one day before D&amp;E procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laminaria</intervention_name>
    <arm_group_label>Laminaria</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dilapan-S</intervention_name>
    <arm_group_label>Dilapan-S</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age and older

          -  Seeking pregnancy termination from 18 0/7 to 24 0/7 weeks of gestation

          -  Eligible for pregnancy termination at Planned Parenthood of New York City

          -  Able to give informed consent

          -  English speaking

        Exclusion Criteria:

          -  • Active bleeding or hemodynamically unstable at enrollment

               -  Signs of chorioamnionitis or clinical infection at enrollment

               -  Signs of spontaneous labor or cervical insufficiency at enrollment

               -  Spontaneous intrauterine fetal demise

               -  Allergy to laminaria or Dilapan-S™
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Principal Investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Planned Parenthood of New York City</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Program Director of Clinical Research</last_name>
    <phone>212-274-7255</phone>
    <email>cti@ppnyc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Planned Parenthood of New York City</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 9, 2014</lastchanged_date>
  <firstreceived_date>January 8, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>abortion</keyword>
  <keyword>cervical dilation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
